News

Home|News

Halberd Corporation Secures $2 Million for Covid-19 Research

Jackson Center, PA, August 4, 2020 – Halberd Corp. (OTC PINK: "HALB") announced today that they have secured non-dilutive, grant-based funding for their patent pending Covid-19 treatment(s).  Newly formed Nonprofit Organization, Epidemiologic Solutions Corporation, a Louisiana, Internal Revenue Code Section 501(c)(3) application pending, has committed to provide funding of approximately $2,000,000, as required by Halberd

By |2020-08-03T21:34:38-04:00August 4th, 2020|Featured, Investor News, News|0 Comments

Halberd Corporation CTO, Dr. Patricio Reyes, Presents Information at Virtual Event on Covid-19’s Effects on Neurological Functions

Jackson Center, PA, July 22, 2020 – Halberd Corporation (OTC Pink: HALB) announced their Chief Technical Officer and Head of Scientific Advisory Board, Dr. Patricio Reyes, presented A Community Information Session virtual event hosted yesterday by the Brain Injury Alliance of Arizona, on “Covid-19 & the Nervous System; Neurological Complications That Can Result”.  Dr. Reyes

By |2020-07-21T21:23:55-04:00July 22nd, 2020|Featured, Investor News, News|0 Comments

Halberd Advances the Treatment of COVID-19 Utilizing Laser Technology

Jackson Center, PA, July 16, 2020 – Halberd Corp. (OTC PINK: "HALB") intends to use laser technology to eradicate the COVID-19 Coronavirus. This patent pending treatment introduces one or more fluorescent antibody-antigen complexing agents to bind with the target antigen(s) (i.e., Covid-19 target antigens). This will allow the virus to be seen and located, and

By |2020-07-15T22:27:36-04:00July 16th, 2020|Featured, Investor News, News|0 Comments

Halberd Corp – Update July 13, 2020 – Addresses Certain Issues

Jackson Center, PA, July 13, 2020 – Halberd Corp. (OTC PINK: "HALB") today issued a statement to clarify certain items within its charter regarding allowable debt.  There have been inaccurate rumors that have put the company in a negative light.  One of these is that the company intends to take on convertible debt. Nothing could

By |2020-07-12T21:15:03-04:00July 13th, 2020|Featured, Investor News, News|0 Comments

COVID-19 Cytokine Storm, Coronavirus’ Deadliest Stage – Halberd’s US Patent Pending Treatment Now Explained!

Jackson Center, PA, July 7, 2020 – Halberd Corp. (OTC PINK: "HALB") today explains the second of three (3) COVID -19 (Coronavirus) patent pending treatments - “Method for Treating Covid-19 Inflammatory Cytokine Storm for the Reduction of Morbidity and Mortality in Covid-19 Patients” - which was filed with the U.S. Patent and Trademark Office on

By |2020-07-06T19:47:51-04:00July 7th, 2020|Featured, News, Technology|0 Comments

Halberd Establishes UK Subsidiary

Jackson Center, PA, July 1, 2020 – Halberd Corporation (OTC-PINK: "HALB") announced the establishment of a subsidiary in the United Kingdom to facilitate access to European research facilities and markets.  The subsidiary is Halberd Corporation UK, Ltd. William A. Hartman, Chairman, President & CEO of Halberd, stated, “This is the first step in our overall

By |2020-07-01T10:06:25-04:00July 1st, 2020|Featured, News|0 Comments

Halberd Method for Treating and Curing the COVID-19 Infection Explained

Jackson Center, PA, June 29, 2020 – Halberd Corporation (OTC-PINK: "HALB") today unveils the first of three (3) COVID -19 (Coronavirus) patent pending treatment methods -- the first titled, “Method for Treating and Curing Covid-19 Infection” -- filed with the U.S. Patent and Trademark Office on March 16, 2020.  Halberd holds exclusive worldwide license to

By |2020-06-28T19:55:51-04:00June 29th, 2020|Featured, News, Technology|0 Comments

NFL Retired Players Association’s Chief Medical Officer Joins Halberd Corporation to Lead COVID-19 Efforts

Effective Immediately! Jackson Center, PA, June 22, 2020 – Halberd Corporation (OTC Pink: HALB) announced the appointment of Dr. Patricio F. Reyes to the position of Chief Technical Officer effective immediately.  He will report to Halberd’s new Chairman, President and CEO, William A. Hartman and is currently the Chief Medical Officer of the NFL’s Retired

By |2020-06-21T20:27:29-04:00June 22nd, 2020|Featured, News, Technology|0 Comments

Halberd Designated “Pink Current Information” by OTC and Continues Technology Progress

Jackson Center, PA, June 15, 2020 –Halberd Corporation (OTC Pink: HALB) announced that OTC Markets has completed its background investigation and analysis of all filings by Halberd Corporation and now designates Halberd Corporation as "Pink Current Information". William A. Hartman, newly appointed Chairman, President and CEO explains, “Now that Halberd has been designated by OTC

By |2020-06-21T04:55:39-04:00June 15th, 2020|Featured, News, Technology|0 Comments